Pelthos Therapeutics Inc. (PTHS) earnings

PTHS earnings moved a median of +2.56% by the close. Quarterly and annual PTHS reports and results, each read against the price at its own news timestamp. Back to the PTHS overview →

11 measured PTHS earnings events.

Where these PTHS earnings landedvs 10 measured PTHS earnings reactions
PTHS earningsMiddle 50% · +0.00% to +4.14%Zero: 0.00%Median: +2.56%Median +2.56%-6.00%0+6.00%
Middle 50% of PTHS earnings reactions+0.00% to +4.14%
Median reaction (to close)+2.56%
Measured reactions10
Point-in-time · zero look-ahead

Half of the 10 PTHS earnings events with a measured close landed between +0.00% and +4.14%; 70% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Pelthos Therapeutics For: Jun 30SEC filing · Form 10-Q+5.83%+4.14%
Form 10-Q/A Pelthos Therapeutics For: Mar 31SEC filing · Form 10-Q+5.83%+4.14%
Pelthos Therapeutics Announces Second Quarter 2026 Financial ResultsPress release+5.83%+4.14%
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026Press release+0.00%-6.35%
Form 10-Q Pelthos Therapeutics For: Mar 31SEC filing · Form 10-Q+1.85%+2.56%
Pelthos Therapeutics Announces First Quarter 2026 Financial ResultsPress release+1.85%+2.56%
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026Press release—-0.28%
Form 10-K Pelthos Therapeutics For: Dec 31SEC filing · Form 10-K+0.00%-7.95%
Form 10-Q Pelthos Therapeutics For: Sep 30SEC filing · Form 10-Q+0.00%—
Pelthos Therapeutics to Report Third Quarter 2025 Financial Results on November 13, 2025Press release—+5.93%
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business UpdatePress release-0.57%+0.85%
That’s how PTHS usually reacts to earnings — get an email when it moves on news →
Keep exploring

More PTHS: analyst actions → · SEC filings → · PTHS overview →